KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Finished Goods (2016 - 2026)

Supernus Pharmaceuticals has reported Finished Goods over the past 13 years, most recently at $21.1 million for Q4 2025.

  • Quarterly Finished Goods rose 28.44% to $21.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.1 million through Dec 2025, up 28.44% year-over-year, with the annual reading at $21.1 million for FY2025, 28.44% up from the prior year.
  • Finished Goods was $21.1 million for Q4 2025 at Supernus Pharmaceuticals, up from $16.7 million in the prior quarter.
  • Over five years, Finished Goods peaked at $46.7 million in Q3 2022 and troughed at $12.5 million in Q3 2021.
  • The 5-year median for Finished Goods is $29.3 million (2023), against an average of $27.6 million.
  • Year-over-year, Finished Goods surged 272.49% in 2022 and then crashed 45.05% in 2024.
  • A 5-year view of Finished Goods shows it stood at $32.9 million in 2021, then grew by 6.34% to $35.0 million in 2022, then decreased by 14.54% to $29.9 million in 2023, then crashed by 45.05% to $16.4 million in 2024, then increased by 28.44% to $21.1 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Finished Goods are $21.1 million (Q4 2025), $16.7 million (Q3 2025), and $20.0 million (Q2 2025).